Impax Asset Management Group plc reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 8.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 191,129 shares of the financial services provider's stock after selling 16,593 shares during the period. Impax Asset Management Group plc owned about 0.05% of CME Group worth $42,173,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the company. Quintet Private Bank Europe S.A. raised its position in CME Group by 29.0% during the third quarter. Quintet Private Bank Europe S.A. now owns 30,287 shares of the financial services provider's stock valued at $6,683,000 after buying an additional 6,815 shares during the period. QRG Capital Management Inc. increased its holdings in shares of CME Group by 4.1% in the 3rd quarter. QRG Capital Management Inc. now owns 31,613 shares of the financial services provider's stock valued at $6,975,000 after purchasing an additional 1,251 shares during the period. Asset Management One Co. Ltd. lifted its position in shares of CME Group by 0.8% in the third quarter. Asset Management One Co. Ltd. now owns 205,347 shares of the financial services provider's stock worth $45,310,000 after purchasing an additional 1,700 shares in the last quarter. National Pension Service boosted its holdings in shares of CME Group by 9.0% during the third quarter. National Pension Service now owns 785,082 shares of the financial services provider's stock worth $173,228,000 after purchasing an additional 64,499 shares during the period. Finally, Cohen Capital Management Inc. grew its position in CME Group by 31.3% during the third quarter. Cohen Capital Management Inc. now owns 2,918 shares of the financial services provider's stock valued at $644,000 after purchasing an additional 696 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Insider Transactions at CME Group
In related news, Director Martin J. Gepsman sold 400 shares of the company's stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Martin J. Gepsman sold 400 shares of the business's stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company's stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. Insiders own 0.30% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on CME shares. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $193.00 to $200.00 and gave the company a "hold" rating in a research note on Thursday, August 15th. Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the company an "equal weight" rating in a research report on Thursday, October 17th. Bank of America upped their target price on CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a research report on Thursday, October 3rd. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a report on Thursday, July 25th. Finally, Piper Sandler increased their price objective on CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a report on Monday, October 28th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $222.73.
Get Our Latest Stock Report on CME Group
CME Group Stock Performance
CME traded up $2.11 during trading on Tuesday, hitting $225.19. The stock had a trading volume of 1,182,438 shares, compared to its average volume of 1,910,700. The firm has a market cap of $81.09 billion, a PE ratio of 23.68, a P/E/G ratio of 5.62 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a 50 day simple moving average of $221.24 and a 200-day simple moving average of $209.67.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company posted $2.25 earnings per share. The firm's revenue for the quarter was up 18.4% on a year-over-year basis. Analysts expect that CME Group Inc. will post 10.23 EPS for the current year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group's dividend payout ratio is 48.37%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
